Ingrid Hsiung
Plano, TXNPI 1427571819
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (48.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 66.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $21,963 and has fallen 71.5% since, to $6,261 in 2025.
Across 224 payments — averaging $137.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$21K
- Medtronic$4K
- Boston Scientific$3K
- Philips North America LLC$1K
- Biosense Webster, Inc.$767
- Shockwave Medical, Inc$125
- plus $280 from 4 others
What the payments were for
- Grants$15,00049%
- Travel & lodging$7,21423%
- Food & beverage$8,09726%
- Education$5852%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 103 | $20,585 |
| Medtronic | 46 | $4,323 |
| Boston Scientific | 44 | $3,436 |
| Philips North America LLC | 11 | $1,380 |
| Biosense Webster, Inc. | 15 | $767 |
| Shockwave Medical, Inc | 1 | $125 |
| Novo Nordisk | 1 | $121 |
| Merck | 1 | $78 |
| Alnylam Pharmaceuticals Inc. | 1 | $54 |
| Abiomed | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$7,686
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$7,678
- ENSITE PRECISION$1,665
- ENSITE$949
- (9520) IGT Devices Undivided$694
- AVEIR$647
- (9124) LM Undivided$368
- Carto 3$354
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$125
- Ozempic$121
- (6554) Peripheral Vascular Undivided$118
- ACCOLADE SR$111
- Micra$105
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 21 | $351 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.